In response to the rising importance of real-world evidence (RWE) in showing value to payers beyond traditional clinical ...

Novo Nordisk continues its efforts to promote the use of genuine, FDA approved GLP-1s while combatting the use of compounded alternatives. This has been a uniquely difficult issue in the weight-loss ...